Methylene blue promotes quiescence of rat neural progenitor cells

Frontiers in Cellular Neuroscience

Volumn 8, Issue OCT, 2014, Pages

  Xie, Luokun ^a   Choudhury, Gourav R ^a   Wang, Jixian ^a   Park, Yong ^a   Liu, Ran ^a   Yuan, Fang ^b   Zhang, Chun Li ^c   Yorio, Thomas ^a   Jin, Kunlin ^a   Yang, Shao Hua ^a,b  

^a UNIVERSITY OF NORTH TEXAS HEALTH SCIENCE CENTER   (United States)

^b CAPITAL MEDICAL UNIVERSITY   (China)

^c UNIVERSITY OF TEXAS SOUTHWESTERN MEDICAL CENTER   (United States)

Author keywords

Methylene blue; Neural progenitor cell; Neurogenesis; Proliferation; Quiescence

Indexed keywords

METHYLENE BLUE;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; APOPTOSIS ASSAY; ARTICLE; CELL CYCLE ASSAY; CELL PROLIFERATION; CONTROLLED STUDY; DOWN REGULATION; MALE; NERVE CELL DIFFERENTIATION; NEURAL STEM CELL; NONHUMAN; RAT; REAL TIME POLYMERASE CHAIN REACTION; SIGNAL TRANSDUCTION; WESTERN BLOTTING;

EID: 84907744665     PISSN: 16625102     EISSN: None     Source Type: Journal    
DOI: 10.3389/fncel.2014.00315     Document Type: Article

References (36)

1. Atamna, H., Nguyen, A., Schultz, C., Boyle, K., Newberry, J., Kato, H.,et al. (2008). Methylene blue delays cellular senescence and enhances key mitochondrial biochemical pathways. FASEB J. 22, 703-712. doi: 10.1096/fj.07-9610com
2. Barkho, B. Z., and Zhao, X. (2011). Adult neural stem cells: response to stroke injury and potential for therapeutic applications. Curr. Stem Cell Res. Ther. 6, 327-338. doi: 10.2174/157488811797904362
3. Bloom, J., and Cross, F. R. (2007). Multiple levels of cyclin specificity in cell-cycle control. Nat. Rev. Mol. Cell Biol.8, 149-160. doi: 10.1038/nrm2105
4. Castilho, R., Squarize, C., Chodosh, L., Williams, B., and Gutkind, J. (2009). mTOR mediates Wnt-induced epidermal stem cell exhaustion and aging. Cell Stem Cell 5, 279-289. doi: 10.1016/j.stem.2009.06.017
5. Chen, C., Liu, Y., Liu, R., Ikenoue, T., Guan, K. L., and Zheng, P. (2008). TSC-mTOR maintains quiescence and function of hematopoietic stem cells by repressing mitochondrial biogenesis and reactive oxygen species. J. Exp. Med. 205, 2397-2408. doi: 10.1084/jem.20081297
6. Chen, C., Liu, Y., and Zheng, P. (2009). mTOR regulation and therapeutic rejuvenation of aging hematopoietic stem cells. Sci. Signal. 2, ra75. doi: 10.1126/scisignal.2000559
7. Cheng, T., Rodrigues, N., Shen, H., Yang, Y., Dombkowski, D., Sykes, M.,et al. (2000). Hematopoietic stem cell quiescence maintained by p21cip1/waf1. Science 287, 1804-1808. doi: 10.1126/science.287.5459.1804
8. Cheung, T. H., and Rando, T. A. (2013). Molecular regulation of stem cell quiescence. Nat. Rev. Mol. Cell Biol. 14, 329-340. doi: 10.1038/nrm3591
9. Congdon, E. E., Wu, J. W., Myeku, N., Figueroa, Y. H., Herman, M.,et al. (2012). Methylthioninium chloride (methylene blue) induces autophagy and attenuates tauopathy in vitro and in vivo. Autophagy 8, 609-622. doi: 10.4161/auto.19048
10. Dormoi, J., Briolant, S., Desgrouas, C., and Pradines, B. (2013). Efficacy of proveblue (methylene blue) in an experimental cerebral malaria murine model. Antimicrob. Agents. Chemother. 57, 3412-3414. doi: 10.1128/AAC.02381-12
11. El-Naggar, S., Liu, Y., and Dean, D. C. (2009). Mutation of the Rb1 pathway leads to overexpression of mTor, constitutive phosphorylation of Akt on serine 473, resistance to anoikis, and a block in c-Raf activation. Mol. Cell. Biol. 29, 5710-5717. doi: 10.1128/MCB.00197-09
12. Fingar, D. C., Richardson, C. J., Tee, A. R., Cheatham, L., Tsou, C., and Blenis, J. (2004). mTOR controls cell cycle progression through its cell growth effectors S6K1 and 4E-BP1/eukaryotic translation initiation factor 4E. Mol. Cell. Biol. 24, 200-216. doi: 10.1128/MCB.24.1.200-216.2004
13. Gage, F. (2000). Mammalian neural stem cells. Science 287, 1433-1438. doi: 10.1126/science.287.5457.1433
14. Han, J., Xiao, Z., Chen, L., Chen, B., Li, X., Han, S.,et al. (2013). Maintenance of the self-renewal properties of neural progenitor cells cultured in three-dimensional collagen scaffolds by the REDD1-mTOR signal pathway. Biomaterials34, 1921-1928. doi: 10.1016/j.biomaterials.2012.11.063
15. He, S., Nakada, D., and Morrison, S. J. (2009). Mechanisms of stem cell self-renewal. Annu. Rev. Cell Dev. Biol. 25, 377-406. doi: 10.1146/annurev.cellbio.042308.113248
16. Imura, T., Kornblum, H. I., and Sofroniew, M. V. (2003). The predominant neural stem cell isolated from postnatal and adult forebrain but not early embryonic forebrain expresses GFAP. J. Neurosci. 23, 2824-2832.
17. Kippin, T., Martens, D., and van der Kooy, D. (2005). p21 loss compromises the relative quiescence of forebrain stem cell proliferation leading to exhaustion of their proliferation capacity. Genes Dev. 19, 756-767. doi: 10.1101/gad.1272305
18. Lange, C., and Calegari, F. (2010). Cdks and cyclins link G1 length and differentiation of embryonic, neural and hematopoietic stem cells. Cell Cycle 9, 1893-1900. doi: 10.4161/cc.9.10.11598
19. Liu, L., and Rando, T. A. (2011). Manifestations and mechanisms of stem cell aging. J. Cell Biol. 193, 257-266. doi: 10.1083/jcb.201010131
20. López-Otín, C., Blasco, M., Partridge, L., Serrano, M., and Kroemer, G. (2013). The hallmarks of aging. Cell 153, 1194-1217. doi: 10.1016/j.cell.2013.05.039
21. Magri, L., Cambiaghi, M., Cominelli, M., Alfaro-Cervello, C., Cursi, M., Pala, M.,et al. (2011). Sustained activation of mTOR pathway in embryonic neural stem cells leads to development of tuberous sclerosis complex-associated lesions. Cell Stem Cell 9, 447-462. doi: 10.1016/j.stem.2011.09.008
22. Matsubara, S., Ding, Q., Miyazaki, Y., Kuwahata, T., Tsukasa, K., and Takao, S. (2013). mTOR plays critical roles in pancreatic cancer stem cells through specific and stemness-related functions. Sci. Rep. 3, 3230. doi: 10.1038/srep03230
23. Patel, P. N. (2006). Methylene blue for management of Ifosfamide-induced encephalopathy. Ann. Pharmacother.40, 299-303. doi: 10.1345/aph.1G114
24. Poteet, E., Choudhury, G. R., Winters, A., Li, W., Ryou, M. G., Liu, R.,et al. (2013). Reversing the Warburg effect as a treatment for glioblastoma. J. Biol. Chem. 288, 9153-9164. doi: 10.1074/jbc.M112.440354
25. Poteet, E., Winters, A., Yan, L. J., Shufelt, K., Green, K. N., Simpkins, J. W.,et al. (2012). Neuroprotective actions of methylene blue and its derivatives. PLoS ONE 7:e48279. doi: 10.1371/journal.pone.0048279
26. Renault, V. M., Rafalski, V. A., Morgan, A. A., Salih, D. A., Brett, J. O., Webb, A. E.,et al. (2009). FoxO3 regulates neural stem cell homeostasis. Cell Stem Cell 5, 527-539. doi: 10.1016/j.stem.2009.09.014
27. Rera, M., Bahadorani, S., Cho, J., Koehler, C., Ulgherait, M., Hur, J.,et al. (2011). Modulation of longevity and tissue homeostasis by the Drosophila PGC-1 homolog. Cell Metab. 14, 623-634. doi: 10.1016/j.cmet.2011.09.013
28. Shyh-Chang, N., Daley, G. Q., and Cantley, L. C. (2013). Stem cell metabolism in tissue development and aging. Development 140, 2535-2547. doi: 10.1242/dev.091777
29. Vadlakonda, L., Pasupuleti, M., and Pallu, R. (2013). Role of PI3K-AKT-mTOR and Wnt signaling pathways in transition of G1-S phase of cell cycle in cancer cells. Front. Oncol. 3:85. doi: 10.3389/fonc.2013.00085
30. Wander, S. A., Hennessy, B. T., and Slingerland, J. M. (2011). Next-generation mTOR inhibitors in clinical oncology: how pathway complexity informs therapeutic strategy. J. Clin. Invest. 121, 1231-1241. doi: 10.1172/JCI44145
31. Wang, S., Xia, P., Ye, B., Huang, G., Liu, J., and Fan, Z. (2013). Transient activation of autophagy via Sox2-mediated suppression of mTOR is an important early step in reprogramming to pluripotency. Cell Stem Cell 13, 617-625. doi: 10.1016/j.stem.2013.10.005
32. Wen, Y., Li, W., Poteet, E. C., Xie, L., Tan, C., Yan, L. J.,et al. (2011). Alternative mitochondrial electron transfer as a novel strategy for neuroprotection. J. Biol. Chem. 286, 16504-16515. doi: 10.1074/jbc.M110.208447
33. Xie, L., Li, W., Winters, A., Yuan, F., Jin, K., and Yang, S. (2013). Methylene blue induces macroautophagy through 5′ adenosine monophosphate-activated protein kinase pathway to protect neurons from serum deprivation. Front. Cell. Neurosci. 7:56. doi: 10.3389/fncel.2013.00056
34. Yilmaz,Ö. H., Katajisto, P., Lamming, D., Gültekin, Y., Bauer-Rowe, K., Sengupta, S.,et al. (2012). mTORC1 in the Paneth cell niche couples intestinal stem-cell function to calorie intake. Nature 486, 490-495. doi: 10.1038/nature11163
35. Zenk, K. E. (2001). Use of methylene blue to treat methemoglobinemia in infancy. Neonatal Netw. 20, 62-68. doi: 10.1891/0730-0832.20.5.62
36. Zhou, J., Su, P., Wang, L., Chen, J., Zimmermann, M., Genbacev, O.,et al. (2009). mTOR supports long-term self-renewal and suppresses mesoderm and endoderm activities of human embryonic stem cells. Proc. Natl. Acad. Sci. U.S.A. 106, 7840-7845. doi: 10.1073/pnas.0901854106